An analysis of B cell adaptive immune receptor sequences in 10 individuals uncovered exceptionally diverse antibody repertoires with a subset of shared antibody clonotypes.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.
There are some deep divisions between the three main databases, some due to competitive pressures and others because of the nature of metabolomics.
In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.
Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.
In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.
The team found that constrained regions of the noncoding genome are up to 52-fold enriched for known pathogenic variants as compared to unconstrained regions.
In Nature this week: genomic analysis of malaria-carrying mosquitos reveals genetic diversity, and more.
A pilot study is to examine whether fitness trackers add to the National Institute of Health's All of Us research initiative, according to FierceHealthcare.
Three changes could transform hemagglutinin of bird flu to bind more tightly to human receptors, a new study says.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.